PACIFIC (Allegro)A 6 month, phase 2, randomized, double-masked, placebo-controlled multicenter clinical trial designed to evaluate the safety and efficacy of Luminate in inducing PVD in subjects with non-proliferative diabetic retinopathy.
PANORAMA (Regeneron)A 2 year, Phase 3, multicenter, randomized study of the efficacy and safety of intravitreal aflibercept (Eylea) injection in patients with moderately severe to severe nonproliferative diabetic retinopathy.
Cystoid Macular Edema after Cataract Surgery (Allergan)
Phase 2 Study of the Dexamethasone Intravitreal Implant (Ozurdex) for combined Pseudophakic Cystoid Edema and Diabetic Macular Edema after cataract surgery.
DA VINCI (Regeneron)
Phase 2 study of the safety, tolerability and biological effect of repeated aflibercept (Eylea) in diabetic macular edema.
Phase 2 study of the efficacy and safety of PF-04523655 versus laser in diabetic macular edema.
Phase 3 study of the efficacy and safety of Ranibizumab (Lucentis) in diabetic macular edema.
A 3 year Phase 3 study of the efficacy, safety and tolerability of aflibercept (Eylea) in patients with diabetic macular edema.